Status:

COMPLETED

Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Lead Sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborating Sponsors:

Yichang Humanwell Pharmaceutical Co., Ltd., China

Conditions:

Mechanically Ventilated Patients

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

This is a Phase II, dose-escalation clinical trial conducted in mechanically ventilated patients receiving sedation no longer than 24 hours. The efficacy, safety, and pharmacokinetics of remimazolam b...

Eligibility Criteria

Inclusion

  • Body mass index (BMI) ≥18 and ≤ 30 kg/m2
  • Being Intubated and mechanically ventilated ≤48 hours before enrollment and expected to be on a ventilator for at least 6 hours
  • Requirement for light to moderate sedation (a Richmond agitation-sedation scale score of -2 to 1)

Exclusion

  • Refusal to be included
  • Allergy or unsuitability to any composition of study drugs or remifentanil
  • Living expectancy less than 48 hours
  • Myasthenia gravis
  • Status asthmaticus
  • Abdominal compartment syndrome
  • Serious hepatic dysfunction (CTP 10-15);
  • Chronic kidney disease with glomerular filtration rate (GFR) \< 29 ml/min/1.73m2
  • Mean blood pressure less than 65 mm Hg or the need for a continuous infusion of norepinephrine at ≥0.5 ug/kg/min to maintain Mean blood pressure ≥ 65 mm Hg
  • Possible requirement for surgery or bedside tracheostomy in 24 hours
  • Possible requirement for renal replacement therapy in 24 hours
  • Acute severe neurological disorder and any other condition interfering with sedation assessment
  • Abuse of controlled substances or alcohol
  • Pregnancy or lactation

Key Trial Info

Start Date :

April 8 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2023

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06124404

Start Date

April 8 2022

End Date

February 28 2023

Last Update

February 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wuhan Union Hospital

Wuhan, Hubei, China, 430022